|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: NOVAVAX INC, 10-Q, 2000-08-14 |
Next: SYNC RESEARCH INC, 10-Q, 2000-08-14 |
<TABLE> <S> <C>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-END> JUN-30-2000
<CASH> 12,285
<SECURITIES> 0
<RECEIVABLES> 668
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 12,996
<PP&E> 2,409
<DEPRECIATION> (959)
<TOTAL-ASSETS> 16,638
<CURRENT-LIABILITIES> 1,714
<BONDS> 0
0
0
<COMMON> 199
<OTHER-SE> 0
<TOTAL-LIABILITY-AND-EQUITY> 16,638
<SALES> 1,298
<TOTAL-REVENUES> 1,298
<CGS> 0
<TOTAL-COSTS> 5,580
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> (3,991)
<INCOME-TAX> 0
<INCOME-CONTINUING> (3,991)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (3,991)
<EPS-BASIC> $(0.22)
<EPS-DILUTED> $(0.22)
</TABLE>
|
|